Pertussis vaccine for adolescents and adults;Vacuna anti-pertussis para uso en adolescentes y adultos

Revista Chilena de Infectologia

Volumn 23, Issue 3, 2006, Pages 257-260

  Perret P , Cecilia ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adolescents; Adults; Efficacy; Immunogenicity; Pertussis; Pertussis vaccine; Review

Indexed keywords

ACELLULAR VACCINE; PERTUSSIS VACCINE;

ADOLESCENT; ADULT; BORDETELLA PERTUSSIS; DISEASE TRANSMISSION; HUMAN; IMMUNIZATION; IMMUNOLOGY; PERTUSSIS; REVIEW;

ADOLESCENT; ADULT; BORDETELLA PERTUSSIS; DISEASE TRANSMISSION, HORIZONTAL; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; IMMUNIZATION, SECONDARY; PERTUSSIS VACCINE; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 33748995393     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Sánchez I, Repetto G, Saenger A. Epidemiología de la tos ferina en Chile (1950-1990). El adulto, ¿nuevo reservorio de infección? Rev Méd Chile 1994; 122: 339-45.
2. Bass J W, Wittler R R. Return of epidemic pertussis in the United States. Pediatr Infect Dis J 1994; 13: 343-5.
3. De Melker H, Schellenkens J E P, Neppelenbroek S E, Mooi Fr, Rumke H C, Conyn-Van Spaendonck M. Re-emergence of pertussis in the highly vaccinated population of the Netherlands: Observations on surveillance data. Emerg Infect Dis 2000; 6: 348-57.
4. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J 1988; 296: 612-4.
5. Nelson J D. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child 1978; 132: 371-3.
6. Crowcroft N S, Booy R, Harrison T, Spicer L, Britto J, Mok Q, et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003; 88: 802-6
7. De Schuter I, Malfroot A, Dab I, Hoebrekx N, Muyldermans G, Pierard D, et al. Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members. Clin Infect Dis 2003; 36: 1391-6.
8. Perret C, Viviani T, Peña A M, Abarca K, Ferrés M. Determinación de la fuente de infección de coqueluche en lactantes menores de 6 meses. XXI Congreso Chileno de Infectología. Viña del Mar 13-16 octubre 2004. resumen CO51, pág 77.
9. Pichichero M, Rennels M, Edwards K, Blatter M, Marshall G S, Bologa M, et al. Combined tetanus, diphtheria, and 5 component pertussis vaccine for use in adolescents and adults. JAMA 2005; 293: 3003-11.
10. Abarca K, Valdivieso F, Potin M, Ibáñez I, Vial P. Inmunogenicidad y seguridad de una vacuna difteria, tétanos, pertussis acelular de contenido antigénico reducido (dTpa) en niños de 10 a 11 años de edad y en adultos. Rev Méd Chile 2002; 130: 502-10.
11. Ward J, Cherry J, Chang S, Partridge S, Lee H, Treamor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555-63.